Bayer AG PK Performance
| BAYRYDelisted Stock | USD 16.86 0.86 5.37% |
The firm shows a Beta (market volatility) of 0.48, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bayer AG's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bayer AG is expected to be smaller as well. Bayer AG PK right now shows a risk of 0.0%. Please confirm Bayer AG PK sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to decide if Bayer AG PK will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bayer AG PK has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Bayer AG is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 4.2 B | |
| Total Cashflows From Investing Activities | 855 M |
Bayer |
Bayer AG Relative Risk vs. Return Landscape
If you would invest 1,686 in Bayer AG PK on January 25, 2024 and sell it today you would earn a total of 0.00 from holding Bayer AG PK or generate 0.0% return on investment over 90 days. Bayer AG PK is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Bayer, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Bayer AG Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bayer AG's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bayer AG PK, and traders can use it to determine the average amount a Bayer AG's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BAYRY |
Based on monthly moving average Bayer AG is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bayer AG by adding Bayer AG to a well-diversified portfolio.
Bayer AG Fundamentals Growth
Bayer Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bayer AG, and Bayer AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bayer Pink Sheet performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0576 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 87.41 B | ||||
| Shares Outstanding | 3.93 B | ||||
| Price To Earning | 12.46 X | ||||
| Price To Book | 1.36 X | ||||
| Price To Sales | 1.02 X | ||||
| Revenue | 44.08 B | ||||
| EBITDA | 6.45 B | ||||
| Cash And Equivalents | 9.07 B | ||||
| Cash Per Share | 2.31 X | ||||
| Total Debt | 35.55 B | ||||
| Debt To Equity | 1.08 % | ||||
| Book Value Per Share | 10.50 X | ||||
| Cash Flow From Operations | 5.09 B | ||||
| Earnings Per Share | 1.28 X | ||||
| Total Asset | 120.24 B | ||||
| Current Asset | 25.17 B | ||||
| Current Liabilities | 16.68 B | ||||
About Bayer AG Performance
To evaluate Bayer AG PK Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bayer AG generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bayer Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bayer AG PK market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Bayer's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States.Things to note about Bayer AG PK performance evaluation
Checking the ongoing alerts about Bayer AG for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bayer AG PK help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bayer AG PK is not yet fully synchronised with the market data | |
| Bayer AG PK has a very high chance of going through financial distress in the upcoming years | |
| Latest headline from seekingalpha.com: Merck garners Canadian approval for Keytruda in first-line gastroesophageal cancer |
- Analyzing Bayer AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bayer AG's stock is overvalued or undervalued compared to its peers.
- Examining Bayer AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bayer AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bayer AG's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bayer AG's pink sheet. These opinions can provide insight into Bayer AG's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Bayer Pink Sheet
If you are still planning to invest in Bayer AG PK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bayer AG's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |